{"transactions":[{"id":934471,"issuer":{"id":5418,"kind":"organization","name":"Cabaletta Bio, Inc."},"owners":[{"id":69079,"kind":"person","name":"Gavel Steve","position":1,"cik":"0002090785","reported_name":"Gavel Steve","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-01-21T18:55:37.000Z","date":"2026-01-21","kind":"purchase","planned":false,"acquired":true,"shares":22170,"price":2.265,"value":50215.05,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased at prices ranging from $2.26 to $2.27, inclusive. The reporting person has provided to the Issuer, and undertakes to provide any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":22170,"source":{"system":"sec-edgar","filing":"0001193125-26-018323","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2090785/000119312526018323/ownership.xml","form_type":"4"}},{"id":1018762,"issuer":{"id":5418,"kind":"organization","name":"Cabaletta Bio, Inc."},"owners":[{"id":69079,"kind":"person","name":"Gavel Steve","position":1,"cik":"0002090785","reported_name":"Gavel Steve","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF COMMERCIAL OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-10-15T16:39:25.000Z","date":"2025-10-13","kind":"grant","planned":false,"acquired":true,"shares":275000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The stock option has been granted pursuant to the Cabaletta Bio, Inc. 2025 Inducement Plan as a material inducement to the Reporting Person's acceptance of employment with the Issuer in accordance with NASDAQ Listing Rule 5635(c)(4)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares underlying this option shall vest and become exercisable on October 13, 2026, with the remainder vesting in twelve substantially equal quarterly installments thereafter, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":275000,"derivative":{"exercise_price":2.49,"expiration_date":"2035-10-12","underlying":"Common Stock","underlying_shares":275000},"source":{"system":"sec-edgar","filing":"0001193125-25-240356","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2090785/000119312525240356/ownership.xml","form_type":"4"}}]}